Jun Quan Xu
No más puestos en curso
Origen de la red de primer grado Jun Quan Xu.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Rady School of Management at UC San Diego
7
| College/University | Other Consumer Services | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jun Quan Xu a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Founder | |
StepStone Group LP
StepStone Group LP Investment ManagersFinance StepStone Group LP (StepStone) is a private equity firm founded in 2006 by Monte M. Brem, Tom Porter Keck and Jose A. Fernandez. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Pharmaceuticals: Major | Private Equity Investor | |
Altegris Advisors LLC
Altegris Advisors LLC Investment ManagersFinance Altegris Advisors LLC (Altegris) is a SEC-registered investment advisor and holding firm headquartered in La Jolla, California. The firm was founded in 2010 by Matthew Osborne and James Waldinger. Altegris serves as the investment adviser to the following categories of Fund clients: (i) Mutual and Closed-End Funds, and their respective subsidiaries, as applicable; and (ii) Private Funds. | Investment Managers | Investment Committee Member | |
University of California | College/University | Undergraduate Degree | |
Powderject Technologies, Inc. | Corporate Officer/Principal | ||
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Pharmaceuticals: Major | Director/Board Member | |
City University of New York | College/University | Doctorate Degree | |
XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Founder | |
Amfora, Inc.
Amfora, Inc. BiotechnologyHealth Technology Amfora, Inc. develops biotechnologies for nutritionally enhanced forage crops. The company was founded by Jonathan Burbaum and is headquartered in San Francisco, CA. | Biotechnology | Founder | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
Innovating Capital
Innovating Capital Investment ManagersFinance Innovating Capital (Innovating Capital) is a venture capital firm founded in 2017 by Pen King and George Lovas,. The firm is headquartered in Greenwich, Connecticut. | Investment Managers | Private Equity Investor | |
HUIFU PAYMENT LIMITED | Regional Banks | Director/Board Member | |
Anderson School of Management | College/University | Corporate Officer/Principal | |
Cheung Kong Graduate School of Business | College/University | Corporate Officer/Principal | |
Shanghai Advanced Institute of Finance | College/University | Corporate Officer/Principal | |
INSIGMA TECHNOLOGY CO., LTD. | Information Technology Services | Director/Board Member | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Doctorate Degree | |
Sorriso Pharmaceuticals, Inc.
Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Chief Executive Officer | |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Pharmaceuticals: Major | Chairman | |
OTONOMY | Biotechnology | Director/Board Member | |
Pembroke College Oxford | College/University | Graduate Degree | |
Siguler Guff & Co. LP
Siguler Guff & Co. LP Investment ManagersFinance Siguler Guff & Co. LP (Siguler Guff) is a private equity firm founded in 1995 by George William Siguler, Andrew Joseph Guff and Donald Paul Spencer. The firm is headquartered in New York.with additional offices Boston, Houstan, London. | Investment Managers | Private Equity Investor | |
YA Global Investments LP
YA Global Investments LP Investment ManagersFinance Part of Yorkville Advisors LLC, YA Global Investments LP acts as a private equity fund. The company is based in Mountainside, NJ. | Investment Managers | Corporate Officer/Principal | |
Siguler Guff Advisers LLC
Siguler Guff Advisers LLC Investment ManagersFinance Siguler Guff Advisers LLC (Siguler Guff) is a registered investment advisor headquartered in New York City. The firm was founded in 1995 and is a wholly owned subsidiary of Siguler Guff & Co. LP. Siguler Guff provides discretionary and non-discretionary investment management services to institutional clients, which includes corporate and public employee benefit plans, endowments, foundations, government agencies and financial institutions, and family office and high net worth investors. | Investment Managers | Portfolio Manager-Fixed Income | |
Banner Ridge Partners LP
Banner Ridge Partners LP Investment ManagersFinance Banner Ridge Partners LP (Banner Ridge Partners) is a private equity firm founded in 2019 by Anthony Michael Cusano and C. J. Driessen. The firm is headquartered in New York. | Investment Managers | Founder | |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
Ziarco Group Ltd.
Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sparrow Pharmaceuticals, Inc.
Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sparrow Pharmaceuticals, Inc. engages in pharmaceuticals industry. It develops drugs for cushing?s syndrome. The company was founded by David A. Katz and is headquartered in Portland, OR. | Pharmaceuticals: Major | Director/Board Member | |
University College Cork | College/University | Undergraduate Degree | |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
University Of Dundee | College/University | Doctorate Degree | |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Private Equity Investor | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Queen's University of Belfast | College/University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 41 |
China | 6 |
Reino Unido | 5 |
Irlanda | 2 |
Sectorial
Health Technology | 25 |
Consumer Services | 14 |
Finance | 11 |
Technology Services | 2 |
Commercial Services | 2 |
Operativa
Director/Board Member | 19 |
Founder | 11 |
Corporate Officer/Principal | 10 |
Doctorate Degree | 7 |
Independent Dir/Board Member | 7 |
Las relaciones más conectadas
Insiders | |
---|---|
Niall O'Donnell | 17 |
Ciara Kennedy | 15 |
Jun Liu | 9 |
Anthony Cusano | 7 |
Steven Prestrelski | 7 |
Jonathan Burbaum | 7 |
Lara M. Magnusen | 3 |
- Bolsa de valores
- Insiders
- Jun Quan Xu
- Conexiones Empresas